2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology …

V Delgado, N Ajmone Marsan, S de Waha… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The changing epidemiology of infective endocarditis in the twenty-first century

J Ambrosioni, M Hernandez-Meneses, A Téllez… - Current infectious …, 2017 - Springer
Abstract Purpose of the Review Infective endocarditis (IE) is a relatively infrequent infectious
disease. It does, however, causes serious morbidity, and its mortality rate has remained …

Association of COVID-19 with endocarditis in patients with cocaine or opioid use disorders in the US

L Wang, ND Volkow, NA Berger, PB Davis… - Molecular …, 2023 - nature.com
The incidence of endocarditis in the US is increasing, driven in part by the rise in
intravenous drug use, mostly opioids and stimulant drugs (cocaine and methamphetamine) …

Clinical characteristics and factors associated with mortality in first-episode infective endocarditis among persons who inject drugs

L Rodger, SD Glockler-Lauf, E Shojaei… - JAMA Network …, 2018 - jamanetwork.com
Importance Persons who inject drugs (PWID) represent a distinct demographic of patients
with infective endocarditis. Many centers do not perform valvular surgery on these patients …

Infective endocarditis by HACEK: a review

M Khaledi, F Sameni, H Afkhami, J Hemmati… - Journal of …, 2022 - Springer
Infective endocarditis (IE) is a severe disease that is still associated with high mortality
despite recent advances in diagnosis and treatment. HACEK organisms (Haemophilus spp …

Staphylococcus aureus bacteraemia and endocarditis – epidemiology and outcome: a review

H Asgeirsson, A Thalme, O Weiland - Infectious Diseases, 2018 - Taylor & Francis
Purpose: To review the epidemiology of Staphylococcus aureus bacteraemia (SAB) and
endocarditis (SAE), and discuss the short-and long-term outcome. Materials and methods: A …

Current challenges in the management of infective endocarditis

G Cuervo, F Escrihuela-Vidal, C Gudiol… - Frontiers in …, 2021 - frontiersin.org
Infective endocarditis is a relatively rare, but deadly cause of sepsis, with an overall mortality
ranging from 20 to 25% in most series. Although the classic clinical classification into …

Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections

NN Tran, T Morrisette, SCJ Jorgensen… - … : The Journal of …, 2023 - Wiley Online Library
Staphylococcus aureus is a major cause of nosocomial and community‐acquired infections
and contributes to significant increase in morbidity and mortality especially when associated …

A contemporary picture of enterococcal endocarditis

JM Pericàs, J Llopis, P Muñoz, J Gálvez-Acebal… - Journal of the American …, 2020 - jacc.org
Background Enterococcal endocarditis (EE) is a growing entity in Western countries.
However, quality data from large studies is lacking. Objectives The purpose of this study was …

[PDF][PDF] 2023 ESC Guidelines for the management of endocarditis

NA Marsan, S de Waha, N Bonaros, S Caselli… - European Heart …, 2023 - academia.edu
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …